PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Modeling Systems

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents - BMSystems co-publishes a new validated systems biology industrial success. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents
BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents

 

NewswireToday - /newswire/ - Paris, Ile-de-France, France, 2010/07/19 - BMSystems co-publishes a new validated systems biology industrial success. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BMSystems & Pherecydes-Pharma publish a validated systems biology industrial success, in a reference US biodefense journal. These disruptive scientific innovations in the fields of biodefense and biosecurity (protection against multi-resistance bacterial infections) are protected by 3 patents.

For more information:

• Download the publication: Genetically Engineered Virulent Phage Banks in the Detection and Control of Emergent Pathogenic Bacteria published in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science publication.

Three opportunities to meet our team in a near future:
• Molecular Microbiology Conference organized by CNRS with the support of INRA, INSERM and Institute Pasteur: Dr. François Iris, CSO, is invited to present BMSystems' expertise and achievements in the field of bacteria/phages interactions: Presqu'ile de Giens France: October 11-15, 2010.

• In the United States, to learn more about possible business collaborations with Pherecydes-Pharma, and about BMSystems' developments in the fields of neurodegenerative diseases, psychiatric disorders and multiple sclerosis.

1. French Biotech Tour in Philadelphia: September 14, 2010, where US Pharma/Biotech companies are invited to meet selected French biotech companies focused in CNS, Autoimmunity and Inflammation.

2. BioPharm America partnering in Boston: September 15-17, 2010.

Bio-Modeling Systems (bmsystems.net) is the first and, to date, the only life sciences research-based Company that succeeded to create and to experimentally validate heuristic in-silico models that led to disruptive discoveries, generating patented new knowledge and attractive new businesses launches.

For sustainable business, time to market is a critical issue. Bio-Modeling Systems, a world leading R&D booster for life sciences discoveries, can surely help you save considerable time and resources immediately.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Modeling Systems

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BMSystems Co-publishes a New Systems Biology Industrial Success Covered by Three Patents

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Manuel Gea - BMSystems.net 
+33(0)6 83 06 12 72 manuel.gea[.]bmsystems.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Modeling Systems securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Modeling Systems / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)